Skip to content

Clinical trials

Phase 3 Shock trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock Phase: Phase 3 Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20051
20061
20082
20092
20101
20111
20123
20131
20141
20151
20161
20181
20192
20203
20211
20222
20234
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status4
Terminated3
Not yet recruiting3
Recruiting3
Withdrawn1
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pharmazz, Inc.2
Anders Perner1
Apex Bioscience1
Arginox Pharmaceuticals1
Assistance Publique - Hôpitaux de Paris1
Australian and New Zealand Intensive Care Research Centre1
B. Braun Melsungen AG1
Central Hospital, Nancy, France1
Centre Hospitalier Universitaire de la Réunion1
Charite University, Berlin, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock34
Sepsis7
Shock, Septic7
Wounds and Injuries5
Hypotension3
Shock, Cardiogenic3
Acidosis2
Acute Kidney Injury2
Critical Illness2
Hemorrhage2

Trials

Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.